COHERUS BIOSCIENCES INC. - COMMON STOCK

Coherus BioSciences Reports First Quarter 2025 Financial Results and Provides Business Update

12 مايو 2025 13:15:13 بحسب Nasdaq GlobeNewswire

Coherus to Report First Quarter 2025 Financial Results on May 12, 2025

05 مايو 2025 13:01:00 بحسب Nasdaq GlobeNewswire

Coherus to Participate in Upcoming Investor Conferences

01 مايو 2025 14:04:28 بحسب Nasdaq GlobeNewswire

Coherus Presents Promising Early Clinical Data from Phase 1 Dose Expansion Study of CHS-114 in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at AACR 2025

28 أبريل 2025 07:10:11 بحسب Nasdaq GlobeNewswire

Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise

14 أبريل 2025 05:00:00 بحسب Nasdaq GlobeNewswire

Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes

01 أبريل 2025 05:00:54 بحسب Nasdaq GlobeNewswire

Coherus to Present Data from a Phase 1 Dose Expansion Study of CHS-114, a Cytolytic Antibody Targeting Chemokine Receptor 8 (CCR8), at the 2025 American Association for Cancer Research (AACR) Annual Meeting

25 مارس 2025 13:30:00 بحسب Nasdaq GlobeNewswire

Coherus BioSciences Reports Fourth Quarter, Full Year 2024 Financial Results and Provides Business Update

10 مارس 2025 13:12:56 بحسب Nasdaq GlobeNewswire

Coherus to Report Fourth Quarter and Full Year 2024 Financial Results on March 10, 2025

03 مارس 2025 05:30:00 بحسب Nasdaq GlobeNewswire

Coherus Management to Participate at the 45th Annual TD Cowen Health Care Conference

24 فبراير 2025 06:08:12 بحسب Nasdaq GlobeNewswire

Coherus Presents Final Phase 2 Clinical Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025

22 يناير 2025 04:00:00 بحسب Nasdaq GlobeNewswire

Coherus Management to Present at the 43rd Annual J.P. Morgan Healthcare Conference

08 يناير 2025 05:00:00 بحسب Nasdaq GlobeNewswire

Coherus to Present Final Phase 2 Casdozokitug Combination Data in Patients with Metastatic Hepatocellular Carcinoma at ASCO-GI 2025

18 ديسمبر 2024 05:30:00 بحسب Nasdaq GlobeNewswire

Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.

03 ديسمبر 2024 04:00:00 بحسب Nasdaq GlobeNewswire

Coherus Management to Participate in the 2024 Citi Global Healthcare Conference

27 نوفمبر 2024 13:01:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

05 نوفمبر 2024 06:45:06 بحسب NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

04 نوفمبر 2024 11:29:16 بحسب NetDania Notify

Coherus to Report Third Quarter 2024 Financial Results on November 6, 2024

30 أكتوبر 2024 13:20:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

29 أكتوبر 2024 06:45:08 بحسب NetDania Notify

NetDania - New 12 months Low: COHERUS BIOSCIENCES INC. - COMMON STOCK

28 أكتوبر 2024 08:42:42 بحسب NetDania Notify